These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37117864)

  • 1. Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease.
    Jo IH; Song DS; Chang UI; Yang JM
    Sci Rep; 2023 Apr; 13(1):6920. PubMed ID: 37117864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.
    Roh E; Hwang SY; Yoo HJ; Baik SH; Lee JH; Son SJ; Kim HJ; Park YS; Lee SG; Cho BL; Jang HC; Kim BJ; Kim M; Won CW; Choi KM
    Hepatol Int; 2022 Jun; 16(3):545-554. PubMed ID: 34780030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng Study.
    Xia MF; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Lin HD; Gao X
    Aliment Pharmacol Ther; 2019 Sep; 50(6):684-695. PubMed ID: 31250467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male.
    Pan XY; Liu WY; Zhu PW; Li G; Tang LJ; Gao F; Huang OY; Yuan HY; Targher G; Byrne CD; Wang XD; Zheng MH
    Hepatol Int; 2022 Oct; 16(5):1085-1093. PubMed ID: 35829867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study.
    Sinn DH; Kang D; Kang M; Guallar E; Hong YS; Lee KH; Park J; Cho J; Gwak GY
    Hepatology; 2022 Dec; 76(6):1746-1754. PubMed ID: 35588190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease.
    Chen LY; Xia MF; Wu L; Li Q; Hu Y; Ma H; Gao X; Lin HD
    World J Diabetes; 2021 Dec; 12(12):2119-2129. PubMed ID: 35047125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosteatosis in nonalcoholic fatty liver disease: An exploratory study.
    De Munck TJI; Verhaegh P; Lodewick T; Bakers F; Jonkers D; Masclee AAM; Verbeek J; Koek GH
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101500. PubMed ID: 32828745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.
    Freer CL; George ES; Tan SY; Abbott G; Scott D; Daly RM
    Calcif Tissue Int; 2024 Jun; 114(6):592-602. PubMed ID: 38678512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty Liver Index and Skeletal Muscle Density.
    Pasco JA; Sui SX; West EC; Anderson KB; Rufus-Membere P; Tembo MC; Hyde NK; Williams LJ; Liu ZSJ; Kotowicz MA
    Calcif Tissue Int; 2022 Jun; 110(6):649-657. PubMed ID: 35028685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects.
    Poggiogalle E; Lubrano C; Gnessi L; Mariani S; Lenzi A; Donini LM
    PLoS One; 2016; 11(1):e0145811. PubMed ID: 26741958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the relationship between four hepatic steatosis indices and muscle mass.
    Lee T; Chung TH
    Sci Rep; 2023 Jan; 13(1):1645. PubMed ID: 36717652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
    Hong KS; Kim MC; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impedance-based measures of muscle mass can be used to predict severity of hepatic steatosis in pediatric nonalcoholic fatty liver disease.
    Yodoshi T; Orkin S; Romantic E; Hitchcock K; Clachar AA; Bramlage K; Sun Q; Fei L; Trout AT; Xanthakos SA; Mouzaki M
    Nutrition; 2021; 91-92():111447. PubMed ID: 34583137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
    Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kang MK; Park JG; Lee HJ; Kim MC
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.
    Yodoshi T; Orkin S; Arce Clachar AC; Bramlage K; Sun Q; Fei L; Beck AF; Xanthakos SA; Trout AT; Mouzaki M
    J Pediatr; 2020 Aug; 223():93-99.e2. PubMed ID: 32711755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.